Stocks · Healthcare · Medical - Healthcare Information Services
American Well Corporation AMWL
$12.39 -3.35% Close, Oct 2, 2026 · NYSE · Market cap $210.7M
Strong trendHigh risk
Next earnings report: Nov 3, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Operating margin widened to -35.2% from -52.2% a year earlier.
- Over the past year the stock returned +100.5%, ahead of the S&P 500 by 85.4 percentage points.
- The stock is in an uptrend: above its 200-day average for 119 trading days, with the 50-day average above the 200-day.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 16%
- Revenue growth, 3-year CAGRBottom 17%
- Revenue growth accelerationBottom 18%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalBottom 40%
- Gross marginBottom 32%
- Operating marginBottom 38%
- Accruals (lower is better)Top 20%
- Interest coverBottom 12%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldBottom 19%
- Free-cash-flow yieldBottom 35%
- EBITDA / enterprise valueBottom 1%
- Sales / enterprise valueTop 1%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthTop 16%
- 6-month returnTop 5%
- 1-year return vs S&P 500Top 15%
- Distance from 52-week highTop 20%
- Trend checklist (0–4)Top 39%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 40%
- Consecutive EPS beatsTop 25%
- Share of analysts rating BuyBottom 5%
- Upside to consensus price targetBottom 14%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 17%
- Maximum drawdown, 3 yearsBottom 19%
- Beta vs S&P 500 (lower is better)Bottom 9%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | -9.3% | -19.0% | ↓ |
| Gross margin | 49.0% | 48.4% | ↓ |
| Operating margin | -52.2% | -35.2% | ↑ |
| FCF margin | -30.7% | -10.8% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | -19.0% | -9.3% | ↓ | Bottom 16% |
| Gross margin | 48.4% | 49.0% | ↓ | Bottom 32% |
| Operating margin | -35.2% | -52.2% | ↑ | Bottom 38% |
| Net margin | -35.7% | -46.2% | ↑ | — |
| Free-cash-flow margin | -10.8% | -30.7% | ↑ | — |
| Return on invested capital | -32.2% | — | Bottom 40% | |
| Revenue growth, 3-year CAGR | -3.5% | — | Bottom 17% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -15.8%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 5.9%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- +17.2 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- Net cash
- Interest cover (operating income / interest)How many times operating profit covers interest.
- -124.8×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -0.29%
- Shareholder yield
- -0.29%
- Share count change, 1 year
- +5.5%
- Share count change, 3-year CAGR
- +5.8%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 4, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 3
- Beats in the last 8 reports
- 7 of 8
- Average EPS surprise, last 4
- +9.1%
- Average 2-day reaction, last 8
- +1.0%
- Positive 20 days after report
- 3 of 8
Analysts
- Consensus price target
- $13.00
- Target vs current price
- +4.9%
- Analysts with a rating
- 15
- Share rating Buy or Strong Buy
- 33%
- Consensus rating
- Hold
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 4, 2026 | +31.4% | -3.2% | +26.2% | +11.2% | — |
| May 5, 2026 | +14.3% | -0.9% | +26.9% | +32.4% | +68.8% |
| Feb 12, 2026 | +10.1% | +0.2% | +32.9% | +27.1% | +84.5% |
| Nov 4, 2025 | -19.4% | -0.8% | -20.6% | -20.0% | -10.6% |
| Aug 5, 2025 | +32.6% | +20.5% | +1.8% | -4.1% | -24.1% |
| May 1, 2025 | +44.0% | -15.6% | -7.5% | -5.7% | +19.0% |
| Feb 12, 2025 | +8.9% | +7.7% | +8.9% | -29.0% | -39.3% |
| Oct 30, 2024 | +13.6% | +0.1% | -7.6% | -6.6% | +10.9% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 4, 2026 | -$0.59 | -$0.86 | +31.4% | $52.0M |
| May 5, 2026 | -$0.66 | -$0.77 | +14.3% | $54.9M |
| Feb 12, 2026 | -$1.43 | -$1.59 | +10.1% | $55.3M |
| Nov 4, 2025 | -$1.74 | -$1.46 | -19.4% | $56.3M |
| Aug 5, 2025 | -$1.24 | -$1.84 | +32.6% | $70.9M |
| May 1, 2025 | -$1.73 | -$3.09 | +44.0% | $66.8M |
| Feb 12, 2025 | -$2.77 | -$3.04 | +8.9% | $71.0M |
| Oct 30, 2024 | -$2.87 | -$3.32 | +13.6% | $61.0M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| EV / Sales | 0.08× | — | — | Top 1% |
| Free-cash-flow yield | -11.21% | — | — | Bottom 35% |
| Earnings yield | -38.50% | — | — | Bottom 19% |
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 119
- 50-day average slope (20 days)
- +10.5%
- 200-day average slope (20 days)
- +12.7%
- Distance from 50-day average
- -0.9%
- Distance from 200-day average
- +52.8%
- RSI (14)
- 43.7
- Relative volume
- 1.46×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 81.8%
- Volatility vs own 5-year history
- 74th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 2.22
- Correlation with S&P 500
- 0.45
- Current drawdown from 1-year high
- -10.7%
- Maximum drawdown, 3 years
- -88.0%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Jan 27, 2021 | Nov 20, 2025 | -99.6% | 1211 days | Not yet recovered |
| Oct 7, 2020 | Nov 17, 2020 | -44.1% | 29 days | 47 days (Jan 27, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $210.7M
- EPS, diluted (TTM)
- -$4.77
- Revenue (TTM)
- $218.5M
- 52-week range
- $3.71 – $14.19
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $252.8M | $277.2M | $259.0M | $254.4M | $249.3M |
| Gross profit | $104.3M | $116.8M | $94.8M | $99.0M | $132.9M |
| Operating income | -$179.1M | -$275.9M | -$692.1M | -$217.5M | -$105.3M |
| Net income | -$176.3M | -$270.4M | -$675.2M | -$208.1M | -$95.7M |
| EPS (diluted) | -$13.88 | -$19.68 | -$47.50 | -$13.88 | -$5.96 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $61.0M | $71.0M | $66.8M | $70.9M | $56.3M | $55.3M | $54.9M | $52.0M |
| Net income | -$43.5M | -$42.7M | -$18.7M | -$19.7M | -$32.4M | -$24.9M | -$10.9M | -$9.9M |
| EPS (diluted) | -$2.87 | -$2.77 | -$1.19 | -$1.24 | -$2.00 | -$1.52 | -$0.66 | -$0.59 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | -$141.5M | -$192.3M | -$148.3M | -$127.3M | -$66.0M |
| Capital expenditure | -$559,000 | -$10.4M | -$15.2M | -$15.2M | -$21,000 |
| Free cash flow | -$142.1M | -$202.8M | -$163.6M | -$142.6M | -$66.0M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | -$15.0M | -$360,000 | -$586,000 | -$3,000 | $840,000 |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $195.9M
- Total assets
- $327.2M
- Total liabilities
- $92.9M
- Total debt
- $3.0M
- Net debt
- -$193.0M
- Shareholders’ equity
- $221.2M
As of Jun 30, 2026 (filed Aug 4, 2026).
Short interest
- Shares sold short
- 160,460
- Days to cover
- 1.40
- Change vs previous report
- +21.4%
FINRA short interest, settlement date Sep 15, 2026.
Stock splits
- Jul 11, 2024
- 1-for-20